Browse the detailed record of transactions filed by Loose Christopher R., Directeur Scientifique. Officer active across 1 companies, notably Frequency Therapeutics, Inc.. Cumulatively, 4 reports have been logged. Total volume traded: €10k. The latest transaction was disclosed on 18 February 2022 (Cession). Regulator: SEC (Form 4). All data is free.
4 of 4 declarations
Christopher R. Loose is the Chief Scientific Officer of Frequency Therapeutics, Inc. In this role, he is responsible for scientific leadership and innovation within the company. Christopher plays a key role in developing new therapies and technologies, thereby contributing to advancements in science and health. His expertise is essential in positioning Frequency Therapeutics as a leader in the biotechnology field.